+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Innovations in Diabetes Cure, Safer CAR-T Therapy, and Pediatric Genetic Disease Treatment

  • ID: 4592933
  • Report
  • June 2018
  • Region: Global
  • 15 pages
  • Frost & Sullivan
1 of 2

The Genetic Technology TechVision Opportunity Engine (TOE) presents trends across diabetes care, CAR-T cell therapy, pedriatic and genetic disease treatment. Novel solutions for pancreatic islet transplants, CAR-T cell therapy, enzyme replacement therapy, and autism correlations are profiled. Clinical trials scenario for Alzheimer's disease is also depicted.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Note: Product cover images may vary from those shown
2 of 2

1. Recent Advances in Diabetes Cure, safer CAR-T Therapy, Pediatric and Genetic Disease Treatment

  • Viable Pancreatic Islet Transplant to Cure Diabetes Permanently
  • Controlled CAR T-cell Therapy with a Safety Switch
  • Enzyme Replacement Therapy to Cure Fatal Genetic Disorder in Infants
  • A Link between Autism in Offsprings and Type 1 Diabetes in Mothers

2. Clinical Trial Analysis and Key Contacts

  • Clinical Trial Analysis of Recombinant Drugs for Treating Alzheimer’s Disease
  • Key Contacts
Note: Product cover images may vary from those shown
3 of 2